rs104886399

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 3P and 6B. PM1PP2BP4BP6BS2

The NM_033380.3(COL4A5):​c.3923A>G​(p.Gln1308Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,209,134 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 13 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Q1308Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000054 ( 0 hom., 3 hem., cov: 24)
Exomes 𝑓: 0.000022 ( 0 hom. 10 hem. )

Consequence

COL4A5
NM_033380.3 missense

Scores

3
5
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 1.19

Publications

3 publications found
Variant links:
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]
COL4A5 Gene-Disease associations (from GenCC):
  • Alport syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P, ClinGen
  • X-linked Alport syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 4 uncertain in NM_033380.3
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 538 curated pathogenic missense variants (we use a threshold of 10). The gene has 138 curated benign missense variants. Gene score misZ: 2.4995 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to X-linked Alport syndrome, Alport syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.3822859).
BP6
Variant X-108677614-A-G is Benign according to our data. Variant chrX-108677614-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 783151.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A5
NM_033380.3
MANE Select
c.3923A>Gp.Gln1308Arg
missense
Exon 44 of 53NP_203699.1P29400-2
COL4A5
NM_000495.5
c.3905A>Gp.Gln1302Arg
missense
Exon 42 of 51NP_000486.1P29400-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A5
ENST00000328300.11
TSL:1 MANE Select
c.3923A>Gp.Gln1308Arg
missense
Exon 44 of 53ENSP00000331902.7P29400-2
COL4A5
ENST00000949143.1
c.3917A>Gp.Gln1306Arg
missense
Exon 42 of 51ENSP00000619202.1
COL4A5
ENST00000361603.7
TSL:2
c.3905A>Gp.Gln1302Arg
missense
Exon 42 of 51ENSP00000354505.2P29400-1

Frequencies

GnomAD3 genomes
AF:
0.0000535
AC:
6
AN:
112080
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000948
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000562
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000564
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000383
AC:
7
AN:
182905
AF XY:
0.0000593
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000732
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000613
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000219
AC:
24
AN:
1097054
Hom.:
0
Cov.:
30
AF XY:
0.0000276
AC XY:
10
AN XY:
362700
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26362
American (AMR)
AF:
0.0000854
AC:
3
AN:
35136
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19346
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30155
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54105
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40478
Middle Eastern (MID)
AF:
0.000244
AC:
1
AN:
4103
European-Non Finnish (NFE)
AF:
0.0000202
AC:
17
AN:
841340
Other (OTH)
AF:
0.0000652
AC:
3
AN:
46029
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000535
AC:
6
AN:
112080
Hom.:
0
Cov.:
24
AF XY:
0.0000876
AC XY:
3
AN XY:
34238
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30882
American (AMR)
AF:
0.0000948
AC:
1
AN:
10543
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.000562
AC:
2
AN:
3561
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2683
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6174
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000564
AC:
3
AN:
53161
Other (OTH)
AF:
0.00
AC:
0
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000341
Hom.:
0
Bravo
AF:
0.000106
ExAC
AF:
0.0000494
AC:
6
EpiCase
AF:
0.0000546
EpiControl
AF:
0.000238

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
1
-
Inborn genetic diseases (1)
-
-
1
X-linked Alport syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.38
CADD
Benign
19
DANN
Benign
0.86
DEOGEN2
Uncertain
0.46
T
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.79
T
M_CAP
Pathogenic
0.31
D
MetaRNN
Benign
0.38
T
MetaSVM
Uncertain
-0.22
T
MutationAssessor
Benign
0.33
N
PhyloP100
1.2
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.78
N
REVEL
Uncertain
0.48
Sift
Benign
0.48
T
Sift4G
Benign
0.55
T
Polyphen
0.64
P
Vest4
0.31
MutPred
0.37
Gain of methylation at Q1302 (P = 0.0168)
MVP
1.0
MPC
0.32
ClinPred
0.15
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.52
gMVP
0.29
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs104886399; hg19: chrX-107920844; API